Citas bibligráficas
Cerna, J., (2021). Asociación entre Síndrome Metabólico y Niveles de Antígeno Prostático Específico en pacientes del Hospital Belén de Trujillo [Tesis, Universidad Privada Antenor Orrego]. https://hdl.handle.net/20.500.12759/7536
Cerna, J., Asociación entre Síndrome Metabólico y Niveles de Antígeno Prostático Específico en pacientes del Hospital Belén de Trujillo [Tesis]. PE: Universidad Privada Antenor Orrego; 2021. https://hdl.handle.net/20.500.12759/7536
@misc{renati/374469,
title = "Asociación entre Síndrome Metabólico y Niveles de Antígeno Prostático Específico en pacientes del Hospital Belén de Trujillo",
author = "Cerna Jamanca, Judith Meliza",
publisher = "Universidad Privada Antenor Orrego",
year = "2021"
}
The objective of the present investigation is to determine if there the association between metabolic syndrome and prostate-specific antigen (PSA) levels. Therefore, an observational, analytical and transversal study was carried out, in which 185 males between 50-70 years were included, who went to prostate control to the Urology Service of the HBT during the period March - July of the year 2019, who fulfilled the Selection criteria. According to the criteria of the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATPIII) patients were dichotomized by the presence or absence of metabolic syndrome and the mean serum PSA levels in each group were calculated. Subsequently, a linear regression analysis was performed to evaluate the effect of age, BMI, prostate volume, plasma volume and urinary tract symptoms score on PSA levels. In the group of men with metabolic syndrome, the mean PSA levels were slightly lower than in men without MetS (1,54 ± 2,39 vs 1,85 ± 3,0); getting a difference of 0.31 ng / ml; however, this association was not statistically significant (p = 0.103). Moreover, PSA levels were influenced by plasma volume (p=0,007) and IMC (p=0.017). The results obtained in this population reflect that there is a non-significant association between metabolic syndrome and PSA levels; However, these findings may be influenced by an antagonistic effect between each of the components of metabolic syndrome.
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons